JNCE Chart
- 52-Week Range: $4.25 - $9.64
- Market Capitalization: $225.30M
- Short Percentage: 0%
- Target Price: $16.29
- Shares Outstanding: 51.67M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
JNCE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Jounce Therapeutics Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire | March 2nd
- Jounce Therapeutics to Participate in Cowen & Co. 42nd Annual Health Care ConferenceGlobeNewsWire | February 28th
- Jounce Therapeutics to Present at Upcoming Investor Conferences in JanuaryGlobeNewsWire | January 4th
- Jounce Therapeutics: A Favorable Risk-Reward Ahead Of Critical 2022 CatalystsSeeking Alpha | December 16th
- Jounce Therapeutics to Present at Upcoming Investor Conferences in NovemberGlobeNewsWire | November 9th
- Jounce Therapeutics, Inc's. (JNCE) CEO Richard Murray on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 4th
- Jounce Therapeutics Appoints Jigar Raythatha to its Board of DirectorsGlobeNewsWire | September 15th
Company Info
Website: https://jouncetx.com
Address: 780 Memorial Drive, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 137
Address: 780 Memorial Drive, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 137
$JNCE come on bulls we can do it
don’t let bears win
$JNCE coming now
$JNCE just hold no panic
$JNCE Looking for this cup to breakout.
$JNCE when is earnings
$JNCE bull flag
breakout!
$JNCE Ride this train. You won't regret.
$JNCE fake wall lets break it
$JNCE about to pop IMHO
$JNCE I like it